Search by Drug Name or NDC
NDC 00187-0006-35 Cabtreo 1.5; 31; 12 mg/g; mg/g; mg/g Details
Cabtreo 1.5; 31; 12 mg/g; mg/g; mg/g
Cabtreo is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch Health US LLC. The primary component is ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE.
MedlinePlus Drug Summary
Adapalene is used to treat acne in adults and children 12 years of and older. Adapalene is in a class of medications called retinoid-like compounds. It works by stopping pimples from forming under the surface of the skin.
Related Packages: 00187-0006-35Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Adapalene
Benzoyl peroxide is used to treat mild to moderate acne.
Related Packages: 00187-0006-35Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Benzoyl Peroxide Topical
Topical clindamycin is used to treat acne. Clindamycin is in a class of medications called lincomycin antibiotics. It works by slowing or stopping the growth of bacteria that cause acne and by decreasing swelling.
Related Packages: 00187-0006-35Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Clindamycin Topical
Product Information
| NDC | 00187-0006 |
|---|---|
| Product ID | 0187-0006_0990acf9-6777-a127-e063-6294a90a3c93 |
| Associated GPIs | |
| GCN Sequence Number | 085426 |
| GCN Sequence Number Description | adapalene/benzoyl/clindamycin GEL (GRAM) 0.15%-3.1% TOPICAL |
| HIC3 | L5H |
| HIC3 Description | ACNE AGENTS,TOPICAL |
| GCN | 54904 |
| HICL Sequence Number | 046076 |
| HICL Sequence Number Description | ADAPALENE/BENZOYL PEROXIDE/CLINDAMYCIN PHOSPHATE |
| Brand/Generic | Brand |
| Proprietary Name | Cabtreo |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | clindamycin phosphate/benzoyl peroxide/adapalene |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GEL |
| Route | TOPICAL |
| Active Ingredient Strength | 1.5; 31; 12 |
| Active Ingredient Units | mg/g; mg/g; mg/g |
| Substance Name | ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
| Labeler Name | Bausch Health US LLC |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE], Retinoid [EPC], Retinoids [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA216632 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00187-0006-35 (00187000635)
| NDC Package Code | 0187-0006-35 |
|---|---|
| Billing NDC | 00187000635 |
| Package | 3.5 g in 1 TUBE (0187-0006-35) |
| Marketing Start Date | 2023-10-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |